| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.26 | 0.06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |